Ronnie Tung‐Ping Poon

13.5k total citations · 5 hit papers
78 papers, 11.0k citations indexed

About

Ronnie Tung‐Ping Poon is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Ronnie Tung‐Ping Poon has authored 78 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hepatology, 31 papers in Surgery and 22 papers in Oncology. Recurrent topics in Ronnie Tung‐Ping Poon's work include Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers) and Liver Disease Diagnosis and Treatment (12 papers). Ronnie Tung‐Ping Poon is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers) and Liver Disease Diagnosis and Treatment (12 papers). Ronnie Tung‐Ping Poon collaborates with scholars based in Hong Kong, China and Taiwan. Ronnie Tung‐Ping Poon's co-authors include John Wong, Chi‐Leung Liu, Chung‐Mau Lo, Irene Oi‐Lin Ng, Chi‐Ming Lam, Wai‐Kuen Tso, Hys Ngan, Sheung Tat Fan, Chung Mau Lo and John Wong and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Ronnie Tung‐Ping Poon

76 papers receiving 10.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

2002 2.0k citations Chung‐Mau Lo, Hys Ngan et al. Hepatology profile →
Risk Factors, Prevention, and Management of Postoperative Recurrence After Resection of Hepatocellular Carcinoma

2000 708 citations Ronnie Tung‐Ping Poon, John Wong et al. Annals of Surgery profile →
Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function

2002 691 citations Ronnie Tung‐Ping Poon, Sheung Tat Fan et al. Annals of Surgery profile →
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

2000 618 citations Ronnie Tung‐Ping Poon, Irene Oi‐Lin Ng et al. profile →
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients

2001 503 citations Ronnie Tung‐Ping Poon, John Wong et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronnie Tung‐Ping Poon Hong Kong	46	7.4k	3.7k	3.4k	2.3k	2.2k	78	11.0k
Ronnie T. P. Poon Hong Kong	54	4.5k 0.6×	2.3k 0.6×	3.0k 0.9×	3.5k 1.5×	2.2k 1.0×	137	10.2k
Tan To Cheung Hong Kong	43	4.3k 0.6×	2.3k 0.6×	2.3k 0.7×	1.6k 0.7×	1.1k 0.5×	252	6.8k
Concepció Brú Spain	35	8.5k 1.1×	5.6k 1.5×	2.7k 0.8×	1.1k 0.5×	1.1k 0.5×	52	10.0k
Jean‐Frédéric Blanc France	41	2.9k 0.4×	1.8k 0.5×	1.4k 0.4×	2.0k 0.9×	1.4k 0.7×	164	6.8k
Baek‐Yeol Ryoo South Korea	50	3.9k 0.5×	1.8k 0.5×	2.1k 0.6×	4.8k 2.0×	1.4k 0.6×	349	10.1k
Tomoo Kosuge Japan	60	3.7k 0.5×	2.8k 0.8×	7.0k 2.0×	7.6k 3.2×	1.7k 0.8×	218	13.7k
Ho Yeong Lim South Korea	58	4.4k 0.6×	2.0k 0.5×	3.6k 1.1×	6.6k 2.8×	2.6k 1.2×	369	15.0k
Lorenza Rimassa Italy	42	2.7k 0.4×	1.2k 0.3×	1.7k 0.5×	3.3k 1.4×	1.2k 0.5×	269	6.6k
Thomas Gruenberger Austria	46	6.3k 0.8×	1.2k 0.3×	3.8k 1.1×	6.7k 2.9×	810 0.4×	192	10.2k
Julien Edeline France	38	3.5k 0.5×	1.3k 0.3×	2.2k 0.6×	2.9k 1.2×	796 0.4×	198	6.9k

Countries citing papers authored by Ronnie Tung‐Ping Poon

Since Specialization

Citations

This map shows the geographic impact of Ronnie Tung‐Ping Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronnie Tung‐Ping Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronnie Tung‐Ping Poon more than expected).

Fields of papers citing papers by Ronnie Tung‐Ping Poon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronnie Tung‐Ping Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronnie Tung‐Ping Poon. The network helps show where Ronnie Tung‐Ping Poon may publish in the future.

Co-authorship network of co-authors of Ronnie Tung‐Ping Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Ronnie Tung‐Ping Poon. A scholar is included among the top collaborators of Ronnie Tung‐Ping Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronnie Tung‐Ping Poon. Ronnie Tung‐Ping Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ng, Lui, Ariel Ka-Man Chow, Thomas Yau, et al.. (2019). Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients. BMC Cancer. 19(1). 713–713. 6 indexed citations

Ho, Ming‐Chih, Kiyoshi Hasegawa, Xiaoping Chen, et al.. (2016). Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer. 5(4). 245–256. 83 indexed citations

Zhu, Andrew X., Baek‐Yeol Ryoo, Chia‐Jui Yen, et al.. (2015). Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of patients with elevated α-fetoprotein (AFP) from the randomized phase III REACH study.. Journal of Clinical Oncology. 33(3_suppl). 232–232. 26 indexed citations

Ng, TP, Chung Mau Lo, Dong Guo, et al.. (2014). Identification of Transmembrane Protein 98 as a Novel Chemoresistance-Conferring Gene in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 13(5). 1285–1297. 33 indexed citations

Bang, Yung‐Jue, Wu‐Chou Su, Do‐Hyun Nam, et al.. (2014). Phase I study of the safety and efficacy of INC280 in patients with advanced MET-dependent solid tumors.. Journal of Clinical Oncology. 32(15_suppl). 2520–2520. 41 indexed citations

Poon, Ronnie Tung‐Ping. (2013). Recent advances in management of hepatocellular carcinoma. 67–68.

Ng, Lui, Ronnie Tung‐Ping Poon, Ariel Ka-Man Chow, et al.. (2013). Suppression of Actopaxin Impairs Hepatocellular Carcinoma Metastasis Through Modulation of Cell Migration and Invasion. Hepatology. 58(2). 667–679. 16 indexed citations

Wong, Carmen Chak‐Lui, Chun‐Ming Wong, Sandy Leung–Kuen Au, et al.. (2010). The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2. Gastroenterology. 140(1). 322–331. 254 indexed citations

Yang, Zhen, Michael Ng, David Ho, et al.. (2008). Significance of local and circulating cancer stem cells in human liver cancer. Cancer Research. 68. 4591–4591. 2 indexed citations

10.

Wong, Danny Ka‐Ho, Man‐Fung Yuen, Ronnie Tung‐Ping Poon, et al.. (2006). Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. Journal of Hepatology. 45(4). 553–559. 77 indexed citations

11.

Poon, Ronnie Tung‐Ping, et al.. (2004). Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma. Annals of Surgical Oncology. 11(3). 281–289. 72 indexed citations

12.

Poon, Ronnie Tung‐Ping, et al.. (2004). Hepatectomy for hepatocellular carcinoma: Patient selection and postoperative outcome. Liver Transplantation. 10(Supplement 2). S39–S45. 183 indexed citations

13.

Poon, Ronnie Tung‐Ping, et al.. (2003). Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surgical Oncology Clinics of North America. 12(1). 35–50. 72 indexed citations

14.

Yuen, Man‐Fung, Ronnie Tung‐Ping Poon, Ching‐Lung Lai, et al.. (2002). A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology. 36(3). 687–691. 129 indexed citations

15.

Lo, Chung‐Mau, Hys Ngan, Wai‐Kuen Tso, et al.. (2002). Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 35(5). 1164–1171. 2020 indexed citations breakdown →

16.

Poon, Ronnie Tung‐Ping, Chung‐Mau Lo, Irene Oi‐Lin Ng, et al.. (2001). Improving Survival Results After Resection of Hepatocellular Carcinoma: A Prospective Study of 377 Patients Over 10 Years. Annals of Surgery. 234(1). 63–70. 472 indexed citations

17.

Poon, Ronnie Tung‐Ping, et al.. (2000). Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. Journal of Surgical Oncology. 73(2). 109–109. 9 indexed citations

18.

Liu, Chi‐Leung, et al.. (2000). Anterior Approach for Major Right Hepatic Resection for Large Hepatocellular Carcinoma. Annals of Surgery. 232(1). 25–31. 156 indexed citations

19.

Poon, Ronnie Tung‐Ping, et al.. (2000). Risk Factors, Prevention, and Management of Postoperative Recurrence After Resection of Hepatocellular Carcinoma. Annals of Surgery. 232(1). 10–24. 708 indexed citations breakdown →

20.

Poon, Ronnie Tung‐Ping, et al.. (1999). Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointestinal Endoscopy. 49(5). 593–598. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact